BCBS Massachusetts Medical Policy Updates – July 2018

July 2018 Medical Policy Updates:

• 004 Immune Modulating Drugs
• 013 Antihyperlipidemics
• 013 Antihyperlipidemics
• 014 follitropin
• 017 Injectable Asthma Medications
• 019 CNS Stimulants and Psychotherapeutic Agents
• 027 Duchenne Muscular Dystrophy (DMD) Medications
• 031 B-Type Natriuretic Peptide
• 036 Phosphodiesterase Type-5 Inhibitors for Pulmonary Arterial Hypertension
• 044 Spinal Muscular Atrophy (SMA) Medications
• 052 Interferons Alpha and Gamma
• 055 Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
• 055 Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
• 102 Opioid Medication Management
• 103 Interleukin-2 (IL-2)
• 107 Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid
• 223 Aqueous Shunts and Stents for Glaucoma
• 223 Aqueous Shunts and Stents for Glaucoma
• 238 Treatment of Varicose Veins and Venous Insufficiency
• 252 Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer
• 257 Growth Hormone and Insulin-like Growth Factor
• 262 Erythropoietin Recombinant Human
• 267 Treatment of Tinnitus
• 283 Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease
• 287 Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
• 296 Home Total Parenteral Nutrition TPN
• 304 Special Foods
• 307 Saturation Biopsy for Diagnosis and Staging of Prostate Cancer
• 310 Intravenous Immunoglobulin
• 333 Gene-Based Tests for Screening, Detection, and Management of Prostate Cancer
• 334 Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
• 344 Pharmacy Hepatitis C Medication Management
• 360 Human Anti hemophilic Factor
• 400 Medical Technology Assessment NonCovered Services
• 409 Oncology Drugs
• 422 RSV Immunoprophylaxis
• 450 Mineral Density Studies
• 464 Implantable Miniature Telescope – IMT
• 465 Lipid Apheresis
• 530 Laboratory Tests for Heart Transplant Rejection
• 547 Ultrasonographic Measurement of Carotid Intima-Medial Thickness as an Assessment of Subclinical Atherosclerosis
• 565 Genetic Testing for Lactase Insufficiency
• 587 Analysis of MGMT Promoter Methylation in Malignant Gliomas
• 587 Analysis of MGMT Promoter Methylation in Malignant Gliomas
• 595 Baroreflex Stimulation Devices
• 613 Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome
• 614 Gene Expression Based Assays for Cancers of Unknown Primary
• 643 Amniotic Membrane and Amniotic Fluid
• 660 Outpatient Cognitive Rehabilitation
• 666 Carrier Screening for Genetic Diseases
• 667 Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA
• 669 Genetic Testing for Mental Health Conditions
• 670 Gene Expression Analysis for Prostate Cancer Management
• 692 Transcatheter Mitral Valve Repair
• 693 Genetic Testing for FLT3 and NPM1 Variants in Cytogenetically Acute Myeloid Leukemia
• 726 Extracorporeal Membrane Oxygenation
• 730 Endovascular Therapies for Extracranial Vertebral Artery Disease
• 802 Genetic Testing for Inherited Thrombophilia
• 803 Genetic Testing for Rett Syndrome
• 911 Gene Therapy for Inherited Retinal Dystrophy Luxturna
• 018 Balloon Dilation of the Eustachian Tube
• 025 AXUMIN (fluciclovine F-18) for Recurrent Prostate Cancer
• 291 Anesthetics for the Treatment of Chronic Pain and Depression
• 661 Surgical and Non-surgical Treatment of Gynecomastia
• 663 Bioengineered Skin and Soft Tissue Substitutes
• 706 Patient-Specific Instrumentation (eg, Cutting Guides) for Joint Arthroplasty

Click here to view the Blue Cross Blue Shield Massachusetts Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.